J
Jacqueline Bromberg
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 113
Citations - 34485
Jacqueline Bromberg is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 54, co-authored 102 publications receiving 27235 citations. Previous affiliations of Jacqueline Bromberg include Kettering University & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.
Dulce M. Barrios M.S,Diana G. Wang,Victoria S. Blinder,Jacqueline Bromberg,Pamela Drullinsky,Samuel Funt,Komal Jhaveri,Diana Lake,Tomas G. Lyons,Shanu Modi,Pedram Razavi,Michelle Sidel,Tiffany A. Traina,Linda T. Vahdat,Mario E. Lacouture +14 more
TL;DR: Rash develops in approximately 50% of breast cancer patients receiving alpelisib, often requiring dose modifications, and herein the characteristics of alpel isib-related Rash are described.
Journal ArticleDOI
Tumour extracellular vesicles and particles induce liver metabolic dysfunction
Gang Wang,Jianlong Li,Linda Bojmar,Haiyan Chen,Zhong Jun Li,Gabriel Cardial Tobias,Mengying Hu,Edwin A. Homan,Serena Lucotti,Fengbo Zhao,Valentina Posada,Peter R. Oxley,Michele Cioffi,Han Sang Kim,Huajuan Wang,Pernille Lauritzen,Nancy Boudreau,Zhanjun Shi,Christin E. Burd,Jonathan H. Zippin,James C. Lo,Geoffrey S. Pitt,Jonathan M. Hernandez,Constantinos P. Zambirinis,Michael A. Hollingsworth,Paul M. Grandgenett,Maneesh Jain,Surinder K. Batra,Dominick J. DiMaio,Jean L. Grem,Kelsey A. Klute,Tanya M. Trippett,Mikala Egeblad,Doru Paul,Jacqueline Bromberg,David P. Kelsen,Vinagolu K. Rajasekhar,John H. Healey,Irina Matei,William R. Jarnagin,Robert E. Schwartz,Haiying Zhang,David Lyden +42 more
Journal ArticleDOI
Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer.
Tomas G. Lyons,Ayca Gucalp,Artavazd Arumov,Sujata Patil,Marcia Edelweiss,Mila Gorsky,Tiffany A. Troso-Sandoval,Jacqueline Bromberg,Rachel Ann Sanford,Neil M. Iyengar,Shanu Modi,Ranju Gupta,Tiffany A. Traina +12 more
TL;DR: This study tests the feasibility of 1 year of adjuvant ENZA for the treatment of early stage, AR+ TNBC (NCT02750358), and reports safety data observed in the phase II trial.
Book ChapterDOI
Constitutively Active STATs and Cellular Transformation
TL;DR: The JAK/STAT pathway is activated by more than 40 ligands including cytokines, growth factors, non-receptor tyrosine kinases and G-proteins and is negatively regulated by a number of molecules.
Journal ArticleDOI
Oral minoxidil for the treatment of late alopecia in cancer survivors.
Alyce Mei Shiuan Kuo,Rachel Reingold,Kwami F. Ketosugbo,Alexander Pan,Stephen W. Dusza,L. Kraehenbuehl,Devika Gajria,Diana Lake,Jacqueline Bromberg,Shari Goldfarb,Tiffany A. Traina,Monica Fornier,Ayca Gucalp,M. Dauscher,Alina Markova,Mario E. Lacouture +15 more
TL;DR: Oral minoxidil may benefit both frontal and occipital late alopecia in cancer survivors treated with cytotoxic and/or endocrine therapy and was well tolerated by patients.